Trials / Unknown
UnknownNCT05275036
Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies
Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies: a Multi-center Prospective Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 493 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
ASCEND-LYM is a prospective, multi-center, observational study aimed at detecting early stage lymphoma and constrcuting prognostic model by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 493 participants including lymphoid malignancies and benign diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | early detection test | Blood collection and early detection testing |
Timeline
- Start date
- 2022-05-31
- Primary completion
- 2023-06-30
- Completion
- 2025-08-31
- First posted
- 2022-03-11
- Last updated
- 2022-04-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05275036. Inclusion in this directory is not an endorsement.